Aptargroup ATR
NYSE ATR
$134.80 +1.84 (+1.38%)
At close: Aug 21, 2026 · 4:00 PM EDT

Aptargroup (ATR) Cash from Investing Activities (2009 - 2026)

Aptargroup (ATR) posted quarterly Cash from Investing Activities of -$56.8 million for Q2 2026, up 18.22% year-over-year from -$48.0 million in Q2 2025, and up 12.77% on a QoQ basis from -$65.1 million in Q1 2026.

Aptargroup (ATR) Cash from Investing Activities (2009 - 2026) Analysis & Trends

Aptargroup has reported Cash from Investing Activities for 18 years, with the latest figure at -$56.8 million in Q2 2026.

  • Cash from Investing Activities for Q2 2026 came in at -$56.8 million, up 18.22% year-over-year; the trailing twelve-month figure through Jun 2026 was -$327.2 million (up 13.38% YoY), and the FY2025 annual result was -$331.4 million, up 16.46% from the prior year.
  • Cash from Investing Activities rose to -$56.8 million in Q2 2026, from -$65.1 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$56.6 million in Q1 2025 and troughed at -$171.1 million in Q4 2024.
  • A 5-year average of -$81.7 million and a median of -$75.1 million in 2023 frame the typical range for Cash from Investing Activities.
  • The widest annual swing landed in 2022, when Cash from Investing Activities surged 59.64%; it then sank 100.96% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$73.2 million in 2022, then decreased by 16.23% to -$85.1 million in 2023, then tumbled by 100.96% to -$171.1 million in 2024, then jumped by 32.01% to -$116.3 million in 2025, then soared by 51.17% to -$56.8 million in 2026.
  • Per Business Quant data, the three most recent Cash from Investing Activities figures were -$56.8 million in Q2 2026, -$65.1 million in Q1 2026, and -$116.3 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn -26.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -241.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -222.00 Mn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -383.65 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn -461.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -43.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -87.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -90.00 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -117.00 Mn
10 Aptargroup 8.58 Bn 8.38 Bn 365.52 Mn -56.79 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -56.79 Mn
Jun 30, 2026 -56.79 Mn
Mar 31, 2026 -65.10 Mn
Mar 31, 2026 -65.10 Mn
Dec 31, 2025 -116.31 Mn
Dec 31, 2025 -116.31 Mn
Sep 30, 2025 -89.05 Mn
Sep 30, 2025 -89.05 Mn
Jun 30, 2025 -69.44 Mn
Jun 30, 2025 -69.44 Mn
Mar 31, 2025 -56.63 Mn
Mar 31, 2025 -56.63 Mn
Dec 31, 2024 -171.07 Mn
Dec 31, 2024 -171.07 Mn
Sep 30, 2024 -80.67 Mn
Sep 30, 2024 -80.67 Mn
Jun 30, 2024 -68.41 Mn
Jun 30, 2024 -68.41 Mn
Mar 31, 2024 -76.57 Mn
Mar 31, 2024 -76.57 Mn